Database test

GE Vivid E9 XDclear ultrasound device including 2D and 4D cardiac, linear, convex and aesophageal probe.

The core facility provides technical services for researchers in a way of biological signals recording, storage and analyses. The CF especially focuses on advanced acquisition and analyses of biological signals using special custom-made technologies. The BME is able to prepare specific setup of the laboratory, technologies, recording systems, etc. needed by researchers.

State-of-the-art acquisition system for experimental neuro-cardiac electrophysiology. Measurement of up to 192 single-ended channels from different sources (EEG, ECG, blood pressure, heart sounds, etc.) + 24 differential channels (external devices) + video and sound. Bit resolution 24bits, sampling up to 50kHz per channel.

The core facility provides technical services for researchers in a way of biological signals recording, storage and analyses. The CF especially focuses on advanced acquisition and analyses of biological signals using special custom-made technologies. The BME is able to prepare specific setup of the laboratory, technologies, recording systems, etc. needed by researchers.

State-of-the-art acquisition system for experimental neuro-cardiac electrophysiology. Measurement of up to 192 single-ended channels from different sources (EEG, ECG, blood pressure, heart sounds, etc.) + 24 differential channels (external devices) + video and sound. Bit resolution 24bits, sampling up to 50kHz per channel.

The core facility provides technical services for researchers in a way of biological signals recording, storage and analyses. The CF especially focuses on advanced acquisition and analyses of biological signals using special custom-made technologies. The BME is able to prepare specific setup of the laboratory, technologies, recording systems, etc. needed by researchers.

State-of-the-art acquisition system for experimental neuro-cardiac electrophysiology. Measurement of up to 192 single-ended channels from different sources (EEG, ECG, blood pressure, heart sounds, etc.) + 24 differential channels (external devices) + video and sound. Bit resolution 24bits, sampling up to 50kHz per channel.

The core facility provides technical services for researchers in a way of biological signals recording, storage and analyses. The CF especially focuses on advanced acquisition and analyses of biological signals using special custom-made technologies. The BME is able to prepare specific setup of the laboratory, technologies, recording systems, etc. needed by researchers.

State-of-the-art acquisition system for experimental neuro-cardiac electrophysiology. Measurement of up to 192 single-ended channels from different sources (EEG, ECG, blood pressure, heart sounds, etc.) + 24 differential channels (external devices) + video and sound. Bit resolution 24bits, sampling up to 50kHz per channel.

The core facility provides technical services for researchers in a way of biological signals recording, storage and analyses. The CF especially focuses on advanced acquisition and analyses of biological signals using special custom-made technologies. The BME is able to prepare specific setup of the laboratory, technologies, recording systems, etc. needed by researchers.

The CliniMACS Prodigy® is a closed and automated platform with the capability to manufacture various cell types on a single device and within a single process setup. It delivers consistent product quality in every batch enabling reproducible cell production.

CTEF-cGMP facility represents a unit for Cell-based Medicinal Products (CBMPs) or Advanced Therapy Products (ATPs) including cell therapy and tissue engineered products. These products are manufactured from viable autologous, allogeneic or xenogeneic cells and they can also contain non cellular components (chemical/biological compounds, matrices, scaffold etc.). All manufacturing and production control activities in CTEF are carried out in accordance with the principles of cGMP quality.

The compact system with innovative acoustic technology is moving ahead with added new functionalities and capabilities making multiparametric flow cytometry available to both new and experienced researchers. Experience the difference acoustic assisted hydrodynamic focusing technology brings to your workflow.

CTEF-cGMP facility represents a unit for Cell-based Medicinal Products (CBMPs) or Advanced Therapy Products (ATPs) including cell therapy and tissue engineered products. These products are manufactured from viable autologous, allogeneic or xenogeneic cells and they can also contain non cellular components (chemical/biological compounds, matrices, scaffold etc.). All manufacturing and production control activities in CTEF are carried out in accordance with the principles of cGMP quality.

Quantum is an automated platform designed to simplify the open, labor-intensive tasks associated with manual cell culture.

CTEF-cGMP facility represents a unit for Cell-based Medicinal Products (CBMPs) or Advanced Therapy Products (ATPs) including cell therapy and tissue engineered products. These products are manufactured from viable autologous, allogeneic or xenogeneic cells and they can also contain non cellular components (chemical/biological compounds, matrices, scaffold etc.). All manufacturing and production control activities in CTEF are carried out in accordance with the principles of cGMP quality.

The Ti's exceptionally stable, drift-free platform is designed to meet the demands of super-resolution imaging while its unique hardware-triggering capabilities enhance even the most challenging, high-speed imaging applications. Furthermore, the Ti2's unique, intelligent functions guide users through imaging workflows by gathering data from internal sensors, eliminating the possibility of user errors. In addition, the status of each sensor is automatically recorded during acquisition, providing quality control for imaging experiments and enhancing data reproducibility.

CTEF-cGMP facility represents a unit for Cell-based Medicinal Products (CBMPs) or Advanced Therapy Products (ATPs) including cell therapy and tissue engineered products. These products are manufactured from viable autologous, allogeneic or xenogeneic cells and they can also contain non cellular components (chemical/biological compounds, matrices, scaffold etc.). All manufacturing and production control activities in CTEF are carried out in accordance with the principles of cGMP quality.

Barrier isolation system provides a physical barrier compared to open fronted clean air devices such as laminar flow clean benches and Class II biological safety cabinets. USP797 guidelines specify that isolators may be situated in an area subject to less severe environmental controls compared with open fronted clean air devices

CTEF-cGMP facility represents a unit for Cell-based Medicinal Products (CBMPs) or Advanced Therapy Products (ATPs) including cell therapy and tissue engineered products. These products are manufactured from viable autologous, allogeneic or xenogeneic cells and they can also contain non cellular components (chemical/biological compounds, matrices, scaffold etc.). All manufacturing and production control activities in CTEF are carried out in accordance with the principles of cGMP quality.